Why Passing Audits No Longer Predicts Scale

A clean audit does not necessarily mean a medical device company is prepared for its next submission, product launch, or acquisition. Teams may pass audits consistently while still reconstructing design history, rebuilding traceability manually, and diverting engineers from higher-value product work. These recurring demands often point to an architectural gap rather than a lack of discipline, especially as organizations grow from 50 to 200 employees. Conventional QMS approaches can begin to strain under increasing scale, M&A activity, and EU MDR requirements. By connecting common warning signs with the operational weaknesses they reveal, leaders can more accurately assess readiness and identify practical improvements. A phased approach can then move the organization toward continuous readiness without the cost and disruption of replacing everything at once.

Read the white paper to test your assumptions about operational readiness.